Dermatitis News

Patients with eczema who were “well-informed” about their condition were more than three times as likely as less informed patients to use shared decision-making with their clinician in the future, according to a study.

Cesarean birth increased risk for atopic dermatitis by age 3 years, especially among infants with eczema, according to a presentation at the European Academy of Allergy and Clinical Immunology Hybrid Congress.

Emollient use did not significantly prevent the development of atopic dermatitis among infants at high risk for the disease, according to a review presented at the European Academy of Allergy and Clinical Immunology Hybrid Congress.

Acne associated with upadacitinib treatment in atopic dermatitis was generally non-severe and manageable, according to study findings.

Male patients experienced more severe objective symptoms with atopic dermatitis than female patients, according to a study presented at European Academy of Allergy and Clinical Immunology Hybrid Congress 2022.

Results of a literature review published in the Journal of the American Academy of Dermatology showed a complex correlation between chronic inflammatory skin disease, such as atopic dermatitis and psoriasis, and sleep loss.

Dupilumab appeared effective and well-tolerated among children and adolescents with moderate to severe atopic dermatitis, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

A 4 mg dose of baricitinib plus topical corticosteroids was associated with significant improvement over placebo in a phase 3 study of patients with moderate to severe atopic dermatitis, according to a study.

Prenatal antibiotic exposure appeared linked to increased susceptibility to childhood asthma and diseases implicated in the atopic march, including wheeze, eczema/dermatitis and allergic rhinitis, according to a review published in Allergy.

Atopic dermatitis may be more prevalent and more severe in patients with skin of color, according to findings published in the Journal of Drugs in Dermatology.